Tag:
HPV
Latest Headlines
Latest Headlines
HPV antibodies point researchers to high risk for oral cancer
With rates of oral cancer linked to HPV infection on the rise, a group of investigators has pinned down a new biomarker that can be used to identify high-risk patients.
Canada's Medicago reports positive early data for H7N9 vaccine
Global concern is growing over the outbreak of H7N9 avian influenza in China. So far, 133 cases of H7N9 sickness have been confirmed, and at least 37 deaths are deaths are thought to have been caused by the disease.
HPV vax awareness uneven despite Merck ad blitz
In 2007, Merck spent $100 million promoting its human papillomavirus vaccine, Gardasil. The advertising blitz helped sales top $1 billion, but earnings fell away quickly over the next few years. Many people are critical of the vaccine, but lots more simply do not know it exists.
GlaxoSmithKline, Merck offer GAVI 95% discount on HPV vaccines
GlaxoSmithKline and Merck are slashing the prices of their HPV vaccinations in a deal with the GAVI Alliance, which delivers immunizations to the developing world.
GSK, Merck agree on HPV vax discount with GAVI
Social issues have held back uptake of GlaxoSmithKline and Merck human papillomavirus (HPV) vaccines in the U.S., but globally the problem is more fundamental--the shots cost too much. It is these low-income countries--where 85% of cervical cancer cases occur--that need the vaccines most though.
Merck's Gardasil looks effective in two-shot regimen
New research suggests that two doses of human papillomavirus vaccine could be as effective as the current three-dose regimen, which would increase uptake.
French biotech Genticel lands $23.7M for 'blockbuster' HPV vaccine hopeful
The company plans to spend the capital on advancing a pipeline of vaccines, including a Phase II trial for a candidate called ProCervix for patients with high-risk cases of human papillomavirus (HPV) infection.
Aussie stats show HPV shots effective, but will U.S. parents listen?
Could Australia's success with HPV vaccination help boost similar efforts in the U.S.? If hard numbers on results could help, then yes. A BMJ study shows that immunizing young women against the human papillomavirus has already proven its worth.
Can public health campaigns goose Gardasil and Cervarix sales?
Public health experts are worried about the latest numbers on HPV vaccine uptake. After all, the shots can prevent cervical cancer, and that's no small thing. so, with a majority of girls eschewing the shots, government officials and others are trying to figure out how to turn the tide.
Struggle against HPV vaccine skepticism intensifying
Convincing patients of the merits of human papillomavirus (HPV) vaccines has proved a tricky task for Merck ($MRK) and GlaxoSmithKline ($GSK).
